January 2026

A listing of the individual articles included in the Jurisdiction E Medicare B News bulletin dated January 2026 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
2025 ICD-10 Billing and Coding Article Updates - Effective October 1, 2025
2026 Medicare Allowances for Portable X-Ray Transportation Codes
2026 Medicare Physician Fee Schedule Now Available
A/B MACs to Return Certain Telehealth and Acute Hospital Care at Home (AHCAH) Claims to Providers
Adding EV Defibrillator Codes to NCD 20.4: ICDs CR14253
Alert: Fraudulent Correspondence Targeting Medicare Providers
Annual Medicare Participation Announcement
ASC Payment System: October 2025 Update CR14246
B-type Natriuretic Peptide (BNP) Testing (L35526) - R12 - Effective October 01, 2019
Billing and Coding: B-type Natriuretic Peptide (BNP) Testing (A57083)- R4 - Effective October 01, 2022
Billing and Coding: Botulinum Toxins Type A and B Policy (A57185) - R10 - Effective October 1, 2025
Billing and Coding: Cataract Surgery in Adults (A57195) - R9 - Effective October 1, 2025
Billing and Coding: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (A57948) - R8 - Effective December 8, 2025
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R22 - Effective October 1, 2025
Billing and Coding: Lab: Bladder/Urothelial Tumor Markers (A55028) - R10 - Effective October 1, 2025
Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (A57423) - R5 - Effective November 7, 2024
Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing (A57268) - R4 - Effective October 1, 2025
Billing and Coding: MolDX: MGMT Promoter Methylation Analysis (A57432) - R3 - Effective October 14, 2021
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R14 - Effective Multiple Dates, 2025
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R25 - Effective October 1, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R30 - Effective October 1, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R31 - Effective October 1, 2025
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R9 - Effective February 10, 2020
Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (A59835) - R1 - Effective August 17, 2025
Billing and Coding: MolDX: Oncotype DX Breast Cancer Assay (A54480) - R5 - Effective November 1, 2019
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R17 - Effective July 3, 2025
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R18 - Effective September 2, 2025
Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (A58183) - R5 - Effective June 2, 2022
Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (A57329) - R5 - Effective February 24, 2022
Billing and Coding: MolDX: Proteomics Testing (A59641) - R11 - Effective October 1, 2025
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R18 - Effective October 1, 2025
Billing and Coding: MRI and CT scans of Head and Neck (A57204) - R15 - Effective October 01, 2025
Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (A58095) - R4 - Effective January 01, 2024
Billing and Coding: Routine Foot Care (A57954) - R17 - Effective October 1, 2025
Billing and Coding: Routine Foot Care (A57954) - R18 - Effective October 1, 2025
Billing and Coding: Routine Foot Care (A57954) - R20 - Effective October 1, 2025
Billing and Coding: Total Knee Arthroplasty (A57685)- R2 - Effective December 1, 2019
Billing and Coding: Wound Care and Debridement - Provided by a Therapist, Physician, NPP or as Incident-to Services (A53296) - R7 - Effective October 01, 2015
Botulinum Toxins Type A and B Policy (L35170) - R15 - Effective October 1, 2019
CAR T-Cell Therapy Claims: End of REMS & KX Modifier Requirement CR14204
CERT Review Contractor Phone Number Misidentified as Spam
Chest X-Ray L37547 - R5 - Effective November 01, 2019
CLFS 2026 Annual Update CR14312
COVID-19 Vaccine Fee Update Mass Adjustment - Resolved 10/22/25 Alert
CWF Errors Leading to Claim Denials Related to Medicare Advantage (MA) Plan Enrollment - Resolved 12/12/2025 Alert
Delayed: Prior Authorization Demonstration for Certain ASC Services
DMEPOS Fee Schedule: October 2025 Quarterly Update - Revised CR14214
DMEPOS Fee Schedules and Labor Payment - 4th quarter 2025 update
DMEPOS Fee Schedules and Labor Payment - 4th Quarter 2025 Updates
Enrollment Address Changes
— 50 Items per Page
Showing 1 - 50 of 104 results.